Insmed to Host First-Quarter 2025 Financial Results Conference Call on Thursday, May 8, 2025

Rhea-AI Summary

Insmed (Nasdaq: INSM) has scheduled its first-quarter 2025 financial results release and conference call for Thursday, May 8, 2025. The company will host an investor conference call at 8:00 a.m. ET on the same day to discuss the financial results and provide a business update.

Participants can join via phone by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) using access code 7862189. The call will be webcast live on www.insmed.com. A replay will be available until May 15, 2025, through phone and a 90-day webcast archive on the company's website.

BRIDGEWATER, N.J., April 23, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that it will release its first-quarter 2025 financial results on Thursday, May 8, 2025.

Insmed management will host a conference call for investors beginning at 8:00 a.m. ET on Thursday, May 8, 2025, to discuss financial results and provide a business update.

Shareholders and other interested parties may participate in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast live on the Company's website at www.insmed.com.

A replay of the conference call will be accessible approximately 1 hour after its completion through May 15, 2025, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call will also be archived for 90 days under the Investor Relations section of the Company's website at www.insmed.com.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's most advanced programs are in pulmonary and inflammatory conditions, including a therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company's early-stage programs encompass a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more.

Contact:

Investors:

Bryan Dunn
Vice President, Investor Relations
(646) 812-4030
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
(862) 842-6819
media@insmed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-to-host-first-quarter-2025-financial-results-conference-call-on-thursday-may-8-2025-302433728.html

SOURCE Insmed Incorporated

FAQ

When will Insmed (INSM) release Q1 2025 earnings?

Insmed will release its Q1 2025 financial results on Thursday, May 8, 2025.

How can investors join Insmed's Q1 2025 earnings call?

Investors can join by dialing (888) 210-2654 (U.S.) or (646) 960-0278 (international) with access code 7862189, or via webcast at www.insmed.com.

How long will Insmed's Q1 2025 earnings call replay be available?

The call replay will be available until May 15, 2025, with the webcast archived for 90 days on Insmed's website.

What time is Insmed's Q1 2025 earnings conference call?

The conference call is scheduled for 8:00 a.m. ET on Thursday, May 8, 2025.